Wahram Andrikyan

8PUBLICATIONS
26CO-AUTHORS
Toxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Modelling and simulationMolecular medicinePharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 16, 2026
Development and analysis of a SmPC-based machine-readable dataset of contraindications for clinical decision support and real-world data analysis.

|Jun 12, 2026
Artificial intelligence-powered chatbots for oral anticancer drug patient information: an assessment of quality.

|Nov 08, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics".

Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe

|Oct 01, 2024
Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients.

Wahram Andrikyan, Sophie Marie Sametinger, Frithjof Kosfeld

|Jul 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC.

Michael I Sponfeldner, Wahram Andrikyan, Renke Maas

|Apr 01, 2023
Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs.

Laura Weisbach, Anna K Schuster, Michael Hartmann

Pageof 2

Frequent Collaborators

7 joint publications

Renke Maas

5 joint publications

Martin F Fromm

3 joint publications

Pauline Dürr

3 joint publications

Michael I Sponfeldner